TREACE MEDICAL CONCEPTS, INC. 8-K

What Happened
Treace Medical Concepts, Inc. announced on January 13, 2026 (Form 8-K) that it issued a press release with preliminary, unaudited financial results for the quarter and the year ended December 31, 2025. The company also posted an investor presentation (Regulation FD disclosure) dated January 13, 2026 and said it will use that presentation at the J.P. Morgan Healthcare Conference on January 14, 2026 (7:30 a.m. PT / 10:30 a.m. ET). A live webcast and archived recording of the conference presentation will be available on the company’s investor relations website. The press release and presentation are furnished as Exhibits 99.1 and 99.2 to the 8-K.

Key Details

• Filing date: January 13, 2026 (Current Report on Form 8-K).
• Item 2.02: Preliminary, unaudited results for the quarter and year ended December 31, 2025 were disclosed via press release (Exhibit 99.1).
• Item 7.01: Investor presentation (dated January 13, 2026) posted to the company website and to be delivered at the J.P. Morgan Healthcare Conference on January 14, 2026; webcast and archived recording will be available (Exhibit 99.2).
• Exhibits furnished with the 8-K: 99.1 (press release) and 99.2 (investor presentation).

Why It Matters
This filing gives investors an early, company‑provided update on Treace’s recent financial performance for Q4 and full‑year 2025 (noting the results are preliminary and unaudited). The investor presentation and JPM conference appearance provide management an opportunity to explain results, outlook and strategy to analysts and investors; the webcast makes the presentation broadly accessible. Investors should review the furnished press release and presentation for the specific financial figures and wait for audited results in future SEC filings for finalized numbers.